Cytokinetics (CYTK) Misses Q3 EPS by 59c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $84.88 -0.79%
Revenue Growth %: -75.1%
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
CRMT, PKE, HELE, More
Revenue Growth %: -75.1%
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($1.35), $0.59 worse than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
- Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
- Vermilion Energy gets TSX approval to repurchase up to 10% of float
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
